Patents by Inventor Xinzhuang ZHANG

Xinzhuang ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158994
    Abstract: An adjustment method of moisture content and dense state for a hydrogel improved subgrade based on weather-resistance during an in-service period, including: step 1: carrying out surface cleaning and compaction of ground; step 2: preparing hydrogel improved subgrade raw material; step 3: paving the prepared material on the surface to form first-layer improved subgrade; and step 4: paving plain soil subgrade onto the first-layer. The method combines the water absorption and release function of the modified resin and the characteristic of the gel state thereof, to pave the improved subgrade in layers, which can absorb water and slightly expand when the water content in the subgrade is increased to a certain threshold value, and a strength and compactness protective layer can also be formed at the connection sections of the ground and the subgrade, and the subgrade and the pavement, to prevent the pot-cover effect from occurring.
    Type: Application
    Filed: October 31, 2022
    Publication date: May 16, 2024
    Applicants: SHANDONG JIAOTONG UNIVERSITY, SHANDONG UNIVERSITY, CHONGQING UNIVERSITY, JINAN JINYUE HIGHWAY ENGINEERING CO., LTD.
    Inventors: Xinzhuang CUI, Jin LI, Qing JIN, Shen ZUO, Dalu XIONG, Peng JIANG, Xiaoning ZHANG, Yefeng DU, Kai YUAN, Chongsheng XIN
  • Publication number: 20230173006
    Abstract: An application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The composition is prepared from the following raw material medicines in parts by weight: 1-3 parts of honey-fried herba ephedrae, 1-10 parts of semen armeniacae amarum, 1-6 parts of radix platycodonis, 1-6 parts of radix peucedani, 1-6 parts of bulbus fritillariae thunbergii, 1-6 parts of radix stemonae, 1-3 parts of oroxylum indicum, 1-10 parts of radix glehniae and 1-3 parts of radix glycyrrhizae. The diluent of the traditional Chinese medicine composition can protect Vero cells infected with 2019-nCov virus.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 8, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Xinzhuang ZHANG, Zhipeng KE, Zhenzhen SU, Xiaoqian TAO, Yi DENG, Zeyu CAO, Liang CAO, Zhenzhong WANG, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230173011
    Abstract: Application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition includes: 2-10 parts of flos lonicerae, 2-10 parts of fructus forsythiae, 2-6 parts of herba menthae, 2-4 parts of herba schizonepetae, 2-5 parts of fermented soybean, 2-6 parts of fried arctii fructus, 2-6 parts of radix platycodonis, 2-4 parts of herba lophatheri and 2-5 parts of radix glycyrrhizae. The traditional Chinese medicine composition has a good effect of treating or preventing coronavirus-related diseases.
    Type: Application
    Filed: March 11, 2021
    Publication date: June 8, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Zhenzhen SU, Xiaoqian TAO, Zhipeng KE, Xinzhuang ZHANG, Zeyu CAO, Yi DENG, Liang CAO, Zhenzhong WANG, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230158095
    Abstract: Application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition includes: 5-30 parts of herba houttuyniae, 5-30 parts of flos lonicerae, 5-20 parts of radix paeoniae rubra, 3-15 parts of folium artemisiae argyi and 3-15 parts of herba menthae. The traditional Chinese medicine composition has a good effect of treating or preventing coronavirus-related diseases.
    Type: Application
    Filed: March 11, 2021
    Publication date: May 25, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Xiaoqian TAO, Xinzhuang ZHANG, Zhenzhen SU, Zhipeng KE, Zeyu CAO, Liang CAO, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230080878
    Abstract: An application of a traditional Chinese medicine composition in preparing a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition is characterized by being prepared from the following raw materials in parts by weight: 5-15 parts of Cornu saigae tataricae or 50-150 parts of goral horns, 10-60 parts of Bulbus Fritillariae Ussuriensis, 15-60 parts of Radix et Rhizoma Rhei, 7-30 parts of Radix scutellariae, 7-30 parts of Lapis Chloriti, 10-50 parts of gypsum fibrosum, 5-20 parts of calculus bovis artifactus, and 15-60 parts of radix glycyrrhizae. The traditional Chinese medicine composition can inhibit 2019-nCoV replication in cells, so that cells infected by 2019-nCoV viruses have no lesion. Therefore, the traditional Chinese medicine composition can treat or prevent coronavirus related diseases.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 16, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Liang CAO, Zhenzhong WANG, Chenfeng ZHANG, Xinzhuang ZHANG, Zeyu CAO